Studies confirm that hyperoxia abnormally activates the Wnt/β‐catenin pathway through the NF‐κB‐Wnt5a signaling axis, leading to alveolarization impairment and fibrosis [150], suggesting Wnt5a as a potential therapeutic target for chronic lung diseases including BPD. The gene discussed is WNT5A; the disease is chronic lung disease.